CANCER DIAGNOSIS AND TREATMENT

摘要

The invention concerns materials and methods relating to the use of OMD (osteomodulin) and/or PRELP (Proline/arginine-rich end leucine-rich repeat protein) expression, particularly under-expression, to discriminate cancer and non-cancer cells in a variety of cancers. The invention further provides methods and materials based on OMD and/or PRELP for use in therapy e.g. to suppress cancer initiation or development.